ELVN Enliven Therapeutics Inc

held by 1 manager in Q2 2025

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.24%	3 mo	NEW	$9M	463,000

Search